Anúncio
Anúncio

AVNS

AVNS logo

Avanos Medical, Inc.

12.35
USD
Patrocinado
+0.09
+0.75%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

12.31

-0.04
-0.34%

Relatórios de Lucros AVNS

Rácio de surpresa positiva

AVNS separação 29 de 40 últimas estimativas.

73%

Próximo Relatório

Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$178.19M
/
$0.25
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+0.22%
/
+13.64%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-0.78%
/
-40.48%

Avanos Medical, Inc. earnings per share and revenue

On 05 de nov. de 2025, AVNS reported earnings of 0.22 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 79.74% surprise. Revenue reached 177.80 milhão, compared to an expected 167.79 milhão, with a 5.97% difference. The market reacted with a -5.66% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of 0.25 USD, with revenue projected to reach 178.19 milhão USD, implying an aumentar of 13.64% EPS, and aumentar of 0.22% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, Avanos Medical, Inc. reported EPS of $0.22, beating estimates by 79.74%, and revenue of $177.80M, 5.97% above expectations.
The stock price moved down -5.66%, changed from $11.30 before the earnings release to $10.66 the day after.
The next earning report is scheduled for 24 de fev. de 2026.
Based on 3 analistas, Avanos Medical, Inc. is expected to report EPS of $0.25 and revenue of $178.19M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio